Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: A systematic review and a meta-analysis

BMC Surgery

Volumn 14, Issue 1, 2014, Pages

  Luan, Haixing ^a   Ye, Feng ^a   Wu, Lupeng ^a   Zhou, Yanming ^a   Jiang, Jie ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Blood transfusion; Lung cancer; Meta analysis; Surgery; Survival

Indexed keywords

BLOOD TRANSFUSION; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; HUMAN; LUNG RESECTION; LUNG TUMOR; META ANALYSIS; MORTALITY; PERIOPERATIVE PERIOD; PROGNOSIS; REVIEW; RISK; STATISTICAL MODEL; SURVIVAL RATE;

BLOOD TRANSFUSION; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; MODELS, STATISTICAL; ODDS RATIO; PERIOPERATIVE CARE; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE;

EID: 84902548835     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-14-34     Document Type: Review

References (31)

1. Immunological abnormalities in patients receiving multiple blood transfusions. Gascon P, Zoumbos NC, Young NS, Ann Intern Med 1984 100 173 177 10.7326/0003-4819-100-2-173 6229206
2. Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset NO) non-oat cell lung cancer. Tartter PI, Burrows L, Kirschner P, J Thorac Cardiovasc Surg 1984 88 659 662 6492836
3. Blood transfusions and survival after lung cancer resection. Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC, Am J Surg 1985 149 502 507 10.1016/S0002-9610(85)80047-7 2984952
4. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Moores DW, Piantadosi S, McKneally MF, Ann Thorac Surg 1989 47 346 351 10.1016/0003-4975(89)90371-8 2539064
5. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A, Staszek VM, Am J Surg 1990 160 630 632 10.1016/S0002-9610(05)80762-7 2174651
6. Perioperative blood transfusion and prognosis of resected state Ia lung cancer. Pastorino U, Valente M, Cataldo I, Lequaglie C, Ravasi G, Eur J Cancer Clin Oncol 1986 22 1375 1378 10.1016/0277-5379(86)90148-3 3030760
7. Blood transfusion and lung cancer recurrence. Keller SM, Groshen S, Martini N, Kaiser LR, Cancer 1988 62 606 610 10.1002/1097-0142(19880801)62: 3<606::AID-CNCR2820620327>3.0.CO;2-Q 3390797
8. The significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small cell lung cancers. Pena CM, Rice TW, Ahmad M, Medendorp SV, Chest 1992 102 84 87 10.1378/chest.102.1.84 1320567
9. Ten-year survival after resection for lung carcinoma. effect of blood transfusion and tumour stage on outcome. Rainio P, Bloigu R, Satta J, Pokela R, Paakko P, Scand J Thor CardioVasc Surg 1996 30 87 91 10.3109/14017439609107248
10. PRISMA group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, PLoS Med 2009 6 1000097 10.1371/journal.pmed.1000097 19621072
11. Laparoscopic versus open hepatic resections for benign and malignant neoplasms-a meta-analysis. Simillis C, Constantinides VA, Tekkis PP, Darzi A, Lovegrove R, Jiao L, Antoniou A, Surgery 2007 141 203 211 10.1016/j.surg.2006. 06.035 17263977
12. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Parmar MK, Torri V, Stewart L, Stat Med 1998 17 2815 2834 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0. CO;2-8 9921604
13. The adverse effect of perioperative blood transfusion in lung cancer. Piantadosi S, Moores DW, McKneally MF, Chest 1994 106 382S 384S 10.1378/chest.106.6-Supplement.382S 7988269
14. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Nosotti M, Rebulla P, Riccardi D, Baisi A, Bellaviti N, Rosso L, Santambrogio L, Chest 2003 124 102 107 10.1378/chest.124.1.102 12853510
15. The influence of blood transfusion on survival in operated non-small cell lung cancer patients. Rzyman W, Dziadziuszko R, Skokowski J, Wilimski R, Raiter A, Szymanowska A, Jassem J, J Thorac Cardiovasc Surg 2003 126 755 760 10.1016/S0022-5223(03)00217-4 14502150
16. Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. effect of allogeneic blood transfusion. Ghosh S, Ahmed K, Hopkinson DN, Vaughan R, Cancer 2004 101 2058 2066 10.1002/cncr.20590 15455359
17. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Berardi R, Brunelli A, Tamburrano T, Verdecchia L, Onofri A, Zuccatosta L, Gasparini S, Santinelli A, Scartozzi M, Valeri G, Giovagnoni A, Giuseppetti GM, Fabris G, Marmorale C, Fianchini A, Cascinu S, Lung Cancer 2005 49 371 376 10.1016/j.lungcan.2005.04.011 15951051
18. Use of blood products in patients treated surgically for stage I non-small cell lung cancer. Peñalver JC, Padilla J, Jordá C, Escrivá J, Cerón J, Calvo V, García A, Pastor J, Blasco E, Arch Bronconeumol 2005 41 484 488 16194510
19. The relationship between prognosis and per ioper ative allogenenic blood transfusions in 280 non- small cell lung cancer patients. Chen J, Jiao S, Chin J Clin Oncol 2007 34 632 635
20. Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies. Thomas P, Michelet P, Barlesi F, Thirion X, Doddoli C, Giudicelli R, Fuentes P, Eur Respir J 2007 29 565 570 10.1183/09031936.00059506 17079259
21. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for nonsmall cell lung cancer. Panagopoulos ND, Karakantza M, Koletsis E, Apostolakis E, Sakellaropoulos GC, Filos KS, Eleni T, Dougenis D, Lung Cancer 2008 62 273 280 10.1016/j.lungcan.2008.02.025 18430486
22. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. Ng T, Ryder BA, Chern H, Sellke FW, Machan JT, Harrington DT, Cioffi WG, J Thorac Cardiovasc Surg 2012 143 815 819 10.1016/j.jtcvs.2011.12.031 22325327
23. Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study. Cata JP, Chukka V, Wang H, Feng L, Gottumukkala V, Martinez F, Vaporciyan AA, BMC Anesthesiol 2013 13 42 10.1186/1471-2253-13-42 24228905
24. Effect of blood transfusions on colonic malignancy recurrent rate. Burrows L, Tartter P, Lancet 1982 2 662
25. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Chung M, Steinmetz OK, Gordon PH, Br J Surg 1993 80 427 432 10.1002/bjs.1800800407 8192723
26. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y, PLoS One 2013 8 64261 10.1371/journal.pone.0064261 23741309
27. The tumor growth-promoting effect of allogeneic blood transfusions. Blajchman MA, Bordin JO, Immunol Invest 1995 24 311 317 10.3109/ 08820139509062781 7713592
28. Inflammation and cancer. Coussens LM, Werb Z, Nature 2002 420 860 867 10.1038/nature01322 12490959
29. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Stephenson KR1, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE, Ann Surg 1988 208 679 687 10.1097/00000658-198812000-00002 3196088
30. Perioperative blood transfusions for the recurrence of colorectal cancer. Amato A, Pescatori M, Cochrane Database Syst Rev 2006 1 CD005033
31. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI, British J Anaesth 2013 110 690 701 10.1093/bja/aet068